1st Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Huan Services Appropriation seeking Food and Drug Administration funding.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Federal Trade Commission (FTC)

Medicare/Medicaid MMM

Communication with Center for Medicare and medicaid Services regarding Innovation center, direct reimbursement under Medicare Program, annual payment updates, and Part D formulary issues. Support for H.R. 592/S. 314, legislation that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 314 (114th), H.R. 592 (114th)

Pharmacy PHA

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning the Drug Quality and Security Act, all titles. Communication with the FDA on labeling of genric medications and biosimilars.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.